Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleTOXICOLOGY

2′-NH2-MPTP [1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2′-CH3-MPTP [1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine]

Erica L. Unger, Pascale Mazzola-Pomietto, Dennis L. Murphy and Anne M. Andrews
Journal of Pharmacology and Experimental Therapeutics November 2002, 303 (2) 527-533; DOI: https://doi.org/10.1124/jpet.102.037614
Erica L. Unger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Mazzola-Pomietto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis L. Murphy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne M. Andrews
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analog, 1-methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine (2′-NH2-MPTP), depletes brain serotonin and norepinephrine in mice without affecting striatal dopamine. The present study was conducted to determine whether 2′-NH2-MPTP would be similarly neurotoxic to rats. Four injections of 20 mg/kg 2′-NH2-MPTP caused 80 to 90% depletions in serotonin and norepinephrine in frontal cortex and hippocampus in rats 1 week post-treatment. A lower dose of 2′-NH2-MPTP (4 × 15 mg/kg) also produced large decrements in serotonin and norepinephrine levels and in serotonin transporter density measured 3 weeks after neurotoxin administration. Furthermore, this lower dose of 2′-NH2-MPTP altered functional serotonin neurotransmission as evidenced by a 2-fold potentiation of 1-(3-chlorophenyl)-piperazine·2HCl-induced hyperthermia, an index of serotonergic denervation supersensitivity. At both doses, 2′-NH2-MPTP was without effect on striatal dopamine. For comparison, additional rats were treated with a second 2′-substituted analog of MPTP, 1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′-CH3-MPTP), at 2 × 20 mg/kg. This dosing regimen causes substantial striatal dopamine depletion in mice. 2′-CH3-MPTP had no effect on brain levels of serotonin, norepinephrine, or dopamine in rats. Together, these results demonstrate that rats are sensitive to the toxic effects of 2′-NH2-MPTP but not to 2′-CH3-MPTP at doses known to cause neurotoxicity in mice. Moreover, this study clearly shows that 2′-NH2-MPTP can be utilized in rats as a tool to study the serotonergic and noradrenergic neurotransmitter systems.

Footnotes

  • Financial support was provided by the National Institute of Mental Health Intramural Program and by the Pennsylvania State University. E.L.U. was supported by a Life Sciences Consortium graduate fellowship from the Pennsylvania State University.

  • Portions of this work have been presented as abstracts at the following meetings: Andrews AM, Mazzola-Pomietto P, and Murphy, DL (1996)2′-NH2-MPTP selectively depletes cortical and hippocampal 5-HT and NE in the rat: a cross-species comparison versus MPTP and 2′-CH3-MPTP, in 1996 Annual Meeting of the American College of Neuropsychopharmacology; 20 December 1996, San Juan, Puerto Rico; Andrews AM, Mazzola-Pomietto P, and Murphy DL: 2′-NH2-MPTP selectively depletes cortical and hippocampal 5-HT and NE in the rat: a comparison with 2′-CH3-MPTP (1997), in Joint Meeting of the International Society for Neurochemistry & the American Society for Neurochemistry; 22 July 1997, Boston, MA.

  • DOI: 10.1124/jpet.102.037614

  • Abbreviations:
    2′-NH2-MPTP
    1-methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine
    MPTP
    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    5-HT
    5-hydroxytryptamine (serotonin)
    NE
    norepinephrine
    DA
    dopamine
    MAO
    monoamine oxidase
    MPP+
    1-methyl 4-phenylpyridinium
    VMAT
    vesicular monoamine transporter
    m-CPP
    1-(3-chlorophenyl)-piperazine·2HCl
    [125I]RTI-55
    [125I]3β-(4-trimethylstannylphenyl)-tropane-2β-carboxylic acid methyl ester
    GBR12935
    1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)homopiperazine
    HPLC
    high-performance liquid chromatography
    2′-CH3-MPTP
    1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine
    5-HIAA
    5-hydroxyindoleacetic acid
    DOPAC
    3,4-dihydroxyphenylacetic acid
    HVA
    homovanillic acid
    • Received April 17, 2002.
    • Accepted June 20, 2002.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 303 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 303, Issue 2
1 Nov 2002
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
2′-NH2-MPTP [1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2′-CH3-MPTP [1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine]
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleTOXICOLOGY

2′-NH2-MPTP [1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2′-CH3-MPTP [1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine]

Erica L. Unger, Pascale Mazzola-Pomietto, Dennis L. Murphy and Anne M. Andrews
Journal of Pharmacology and Experimental Therapeutics November 1, 2002, 303 (2) 527-533; DOI: https://doi.org/10.1124/jpet.102.037614

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleTOXICOLOGY

2′-NH2-MPTP [1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2′-CH3-MPTP [1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine]

Erica L. Unger, Pascale Mazzola-Pomietto, Dennis L. Murphy and Anne M. Andrews
Journal of Pharmacology and Experimental Therapeutics November 1, 2002, 303 (2) 527-533; DOI: https://doi.org/10.1124/jpet.102.037614
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nafamostat is a Potent Human Diamine Oxidase Inhibitor
  • Chemoproteomics Investigation of Testicular Toxicity with BTK Inhibitor
  • Bosentan Alters Bile Salt Disposition
Show more Toxicology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics